Clinical trial · Interventional
Protein Classifier for Thyroid Indeterminate Nodules
Protein Classifier for Thyroid Indeterminate Nodules： a Multi-center Prospective Clinical Study
NCT04477798CI-TRIAL-00046034unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In multi-center, prospective, double-blind cohorts, PCT-DIA/MS protein classifier supported by artificial neural networks will be validated to classify thyroid indeterminate nodules.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Thyroid Nodule | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| PCT-DIA/MS | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- PCT-DIA/MS
- description
- PCT-DIA/MS protein classifier supported by artificial neural networks will be validated to classify thyroid indeterminate nodules
- interventionNames
- Diagnostic Test: PCT-DIA/MS
Primary outcomes (1)
- measure
- protein classifier
- timeFrame
- immediately after the procedure
- description
- classify thyroid indeterminate nodules as Benign or Malignant
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients with aged 18 to 70 years old; 2. Patients with thyroid nodules who have not been treated with drugs; 3. Patients who were diagnosed as Bethesda III and IV by cytology and pathology before operation; 4. Patients who underwent total / partial thyroidectomy and had histopathological reports of corresponding cellular pathological punctured nodules; 5. Patients voluntarily participate in the study after informed consent. Exclusion Criteria: 1. Patients without operation; 2. Patients with insufficient FNA sample size (judged by the laboratory).
References
Publications (0)
Data not yet available
No reference posted for this study.